Oral Abstract Session
Onconephrology: Models, Markers, and Medications
October 25, 2024 | 04:30 PM - 06:00 PM
Location: Room 33, Convention Center
Session Description
Oral Abstract Session
Learning Pathway(s)
- Onconephrology
Moderators
Presentations
- VHL-Deficient Human Kidney Organoids to Model Clear Cell Renal Cell Carcinoma
04:30 PM - 04:40 PM
- Macrophages as Potential Mediators of Lung Cancer-Kidney Cross-Talk
04:40 PM - 04:50 PM
- Single-Cell RNA Sequencing Reveals Conserved T Cell Populations Detected across Inflamed Kidney Tissue and Urine of Patients with Immune Checkpoint Inhibitor-Associated Nephritis
04:50 PM - 05:00 PM
- Association of Novel Urine Biomarkers with Immune Checkpoint Inhibitor Nephrotoxicity
05:00 PM - 05:10 PM
- Fludeoxyglucose F 18 Positron Emission Tomography/Computed Tomography: A Novel Diagnostic Tool for Immune Checkpoint Inhibitor-Associated AKI
05:10 PM - 05:20 PM
- Effect of Intravenous Magnesium on Cisplatin-Associated AKI
05:20 PM - 05:30 PM
- Post-transplantation Cyclophosphamide-Based Regimen for Graft-vs.-Host Disease Prophylaxis Reduces Risk of CKD in Allogenic Stem-Cell Transplant Recipients
05:30 PM - 05:40 PM
- Exposure to Glucagon-Like Peptide 1 Receptor Agonists Does Not Increase the Risk of AKI Associated with Anticancer Therapy
05:40 PM - 05:50 PM
- Cancer Incidence and Outcomes in the Dialysis Population: Nationwide Registry Analysis of Time Trends and Outcomes
05:50 PM - 06:00 PM